These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12775588)

  • 1. Information from drug companies and opinion leaders.
    Liberati A; Magrini N
    BMJ; 2003 May; 326(7400):1156-7. PubMed ID: 12775588
    [No Abstract]   [Full Text] [Related]  

  • 2. [The fight for existence].
    Haug C
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1817. PubMed ID: 12830248
    [No Abstract]   [Full Text] [Related]  

  • 3. [The medical journals are an outstanding resource of knowledge on drug news].
    Overby A
    Lakartidningen; 1991 Jun; 88(26-27):2384. PubMed ID: 1857162
    [No Abstract]   [Full Text] [Related]  

  • 4. The CPS: love, hate and expectations.
    Repchinsky C
    Can J Clin Pharmacol; 2002; 9(2):62-3. PubMed ID: 12172584
    [No Abstract]   [Full Text] [Related]  

  • 5. Found: alternative to the "Compendium of pharmaceuticals and specialties" (CPS).
    Biron P
    Can Med Assoc J; 1977 Apr; 116(7):720, 724. PubMed ID: 849551
    [No Abstract]   [Full Text] [Related]  

  • 6. Information responsibilities of generic drug companies.
    Cramer R
    Am J Hosp Pharm; 1986 Jul; 43(7):1674, 1679. PubMed ID: 3752098
    [No Abstract]   [Full Text] [Related]  

  • 7. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan.
    Rohra DK; Gilani AH; Memon IK; Perven G; Khan MT; Zafar H; Kumar R
    J Pharm Pharm Sci; 2006; 9(1):50-9. PubMed ID: 16849008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of services provided by pharmaceutical companies: perceptions of physicians and pharmaceutical sales representatives.
    Gaedeke RM; Tootelian DH; Sanders EE
    Health Mark Q; 1999; 17(1):23-31. PubMed ID: 11066720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Can we rely on drug information?].
    Myhr K
    Tidsskr Nor Laegeforen; 2002 Nov; 122(27):2644-6. PubMed ID: 12523198
    [No Abstract]   [Full Text] [Related]  

  • 10. Sponsorship, authorship, and accountability.
    Davidoff F; DeAngelis CD; Drazen JM; Nicholls MG; Hoey J; Højgaard L; Horton R; Kotzin S; Nylenna M; Overbeke AJ; Sox HC; Van Der Weyden MB; Wilkes MS
    N Engl J Med; 2001 Sep; 345(11):825-6; discussion 826-7. PubMed ID: 11556304
    [No Abstract]   [Full Text] [Related]  

  • 11. Quality of drug information service provided by pharmaceutical manufacturers.
    Doyal LE
    Am J Hosp Pharm; 1990 May; 47(5):1014. PubMed ID: 2337090
    [No Abstract]   [Full Text] [Related]  

  • 12. 2010 Prescrire Information Awards.
    Prescrire Int; 2011 Mar; 20(114):82. PubMed ID: 21648236
    [No Abstract]   [Full Text] [Related]  

  • 13. Is drug advertising informing the consumer?
    Hanlon PM
    Behav Healthc Tomorrow; 2002 Feb; 11(1):SR35-7. PubMed ID: 11837141
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulating manufacturer-affiliated communication in the information age.
    Schulman KA; Abernethy DR; Rathore SS; Woosley RL
    Clin Pharmacol Ther; 1999 Jun; 65(6):593-7. PubMed ID: 10391664
    [No Abstract]   [Full Text] [Related]  

  • 15. Sponsorship, authorship, and accountability.
    Loder E
    N Engl J Med; 2002 Jan; 346(4):290-2. PubMed ID: 11808617
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulating drug information in Europe: a pyrrhic victory for pharmaceutical industry critics?
    Mulinari S
    Sociol Health Illn; 2013 Jun; 35(5):761-77. PubMed ID: 23094890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of the pharmaceutical industry in medicine.
    Jelinek GA; Neate SL
    J Law Med; 2009 Oct; 17(2):216-23. PubMed ID: 19998591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of information received from pharmaceutical companies.
    Wilson DE; Crabbe SJ
    DICP; 1990 Nov; 24(11):1117. PubMed ID: 2275242
    [No Abstract]   [Full Text] [Related]  

  • 19. Prohibited abbreviations.
    Nagel KR
    Am J Health Syst Pharm; 2005 Aug; 62(15):1559. PubMed ID: 16030363
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug control within the EEC II: good possibilities for Sweden].
    Strandberg K
    Lakartidningen; 1992 Jan; 89(4):178-9. PubMed ID: 1734147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.